Trimethylamine-N-oxide is an important target for heart and brain diseases
Shusi Ding1
Jing Xue1
Qi Zhang2
Lemin Zheng3
1.China National Clinical Research Center of Neurological Diseases,Beijing Tiantan Hospital,Capital Medical University,Beijing,China2.School of Basic Medical Sciences,The Institute of Cardiovascular Sciences and Institute of Systems Biomedicine,Peking University,Beijing,China3.China National Clinical Research Center of Neurological Diseases,Beijing Tiantan Hospital,Capital Medical University,Beijing 100050,China;School of Basic Medical Sciences,Health Sciences Center,The Institute of Cardiovascular Sciences and Institute of Systems Biomedicine,Peking University,Xueyuan Road NO.38,Haidian District,Beijing 100871,China
摘要:Trimethylamine-N-oxide (TMAO) is a metabolite produced from dietary nutrients by the gut microbiome, which was first discovered in 2011 and used to predict the risk of car-diovascular disease [1].
机标关键词:targetheartoxidebraindiseasesimportanttrimethylamine
论文发表日期:2022-08-28
在线出版日期:2025-08-15(本平台首次上网日期,不代表文献的发表时间)
页数:3( 321-323 )